Highlights Cyclopharm Limited

Equities

CYC

AU000000CYC5

Delayed Australian S.E. Other stock markets 02:10:07 2024-06-25 EDT			5-day change	1st Jan Change
1.615 ^AUD	+1.25%		+5.56%	-16.10%

05-27	Cyclopharm Raises AU$20 Million Share Placement for Technegas Commercialization; Shares Down 16%	MT
05-24	Cyclopharm to Raise AU$20 Million via Placement, AU$2 Million via Share Purchase Plan	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Cyclopharm Raises AU$20 Million Share Placement for Technegas Commercialization; Shares Down 16%	05-27	MT
Cyclopharm Limited Reports Earnings Results for the Full Year Ended December 31, 2023	02-27	CI
Cyclopharm Signs First US Deal for Inhalable Imaging Product	12-05	MT
Cyclopharm Advances Rollout of Imaging Drug in the US	11-15	MT
Cyclopharm Secures US FDA Clearance for Inhalable Imaging Product; Shares Rise 5%	23-10-02	MT
Ex-dividend day for interim dividend	23-08-31	FA
Cyclopharm Limited Declares Unfranked Interim Dividend for the Six Months Ended June 30, 2023, Payable on 11 September 2023	23-08-21	CI
Cyclopharm Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-21	CI
US FDA Completes Site Inspection for Cyclopharm’s Technegas Facility	23-08-08	MT
Cyclopharm Secures US FDA Inspection Date for Imaging Drug Production Facility; Shares Rise 4%	23-05-09	MT
US FDA Confirms Receipt of Cyclopharm's Response Submission for Inhalable Imaging Agent	23-04-24	MT
Cyclopharm Takes Over Denmark-based DuPharma ApS	23-04-19	MT
Cyclopharm Limited acquired Dupharma Aps.	23-04-19	CI
Cyclopharm Files Formal Reply to US FDA for Inhalable Imaging Agent	23-03-30	MT
Final dividend	23-03-26	FA
Cyclopharm Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-19	CI
Cyclopharm Limited Announces Dividend for A Period of Six Months Ended December 31, 2022, Payable on April 4 2023	23-02-19	CI
Cyclopharm Receives $1.1 Million R&D Tax Rebate	22-11-29	MT
Ex-dividend day for interim dividend	22-09-01	FA
Cyclopharm Narrows Net Loss in H1; Shares Jump 6%	22-08-16	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Cyclopharm Limited

Equities

CYC

AU000000CYC5

Highlights

Filters